Abstract

Literature Review

Looking Beyond Common Causes of Renal Dysfunction: Renal GVHD and Thrombotic Microangiopathy after Allogeneic Transplant

Taner Tan*, Ahmet Umur Topcu, Erdem Cig, Dilek Ertoy Baydar and Sinem Civriz Bozdag

Published: 03 March, 2026 | Volume 10 - Issue 1 | Pages: 001-003

Renal dysfunction after allogeneic hematopoietic stem cell transplantation (allo-HSCT) often results from common causes like drug toxicity, infection, or transplant-associated thrombotic microangiopathy (TA-TMA). However, renal graft-versus-host disease (GVHD) may be ignored. We discuss a 49-year-old man who experienced worsening kidney function despite being in hematologic remission and having negative results for infections and autoimmune diseases. A renal biopsy showed chronic tubulointerstitial injury consistent with renal GVHD, along with existing TMA. Treatment with eculizumab did not lead to improvement, likely indicating significant chronic damage. This case highlights the need to maintain clinical suspicion and to perform timely renal biopsies in cases of unexplained kidney dysfunction after transplant.

Read Full Article HTML DOI: Cite this Article Read Full Article PDF

Keywords:

GVHD; Kidney; Thrombotic microangiopathy; Allogeneic transplantation; Renal biopsy

References

  1. Desai N, Law AD, Bourlon C, John R, Kitchlu A, Chan C, et al. Renal involvement in chronic graft-versus-host disease. Eur J Haematol. 2025;115(6):547-54. Available from: https://doi.org/10.1111/ejh.70020
  2. Roy G, Iordachescu I, Royal V, Lamarche C, Ahmad I, Nadeau-Fredette AC, Laurin LP. Kidney biopsy findings among allogenic hematopoietic stem cell transplant recipients with kidney injury: A case series. Kidney Med. 2023;5(7):100674. Available from: https://doi.org/10.1016/j.xkme.2023.100674
  3. Sakellari I, Barbouti A, Bamichas G, Mallouri D, Kaloyannidis P, Fragidis S, et al. GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation. Bone Marrow Transplant. 2013;48(10):1329-34. Available from: https://doi.org/10.1038/bmt.2013.55
  4. Brukamp K, Doyle AM, Bloom RD, Bunin N, Tomaszewski JE. Nephrotic syndrome after hematopoietic cell transplantation: Do glomerular lesions represent renal graft versus-host disease? Clin J Am Soc Nephrol. 2006;1(4):685-94. Available from: https://doi.org/10.2215/cjn.00380705
  5. Carrasco-Yalán A, Murillo-Vizcarra S, Moreno-Larrea M, Chumpitaz-Anchiraico G, Castillo-Aguirre J, Mendoza S, et al. Proteinuria related to chronic graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2004;10:49. Available from: https://doi.org/10.1016/j.bbmt.2003.12.243
  6. Girsberger M, Halter JP, Hopfer H, Dickenmann M, Menter T. Kidney pathology after hematologic cell transplantation—a single-center observation study of indication biopsies and autopsies. Biol Blood Marrow Transplant. 2018;24(3):571-80. Available from: https://doi.org/10.1016/j.bbmt.2017.11.008
  7. Cohen EP, Pais P, Moulder JE. Chronic kidney disease after hematopoietic stem cell transplantation. Semin Nephrol. 2010;30(6):627-34. Available from: https://doi.org/10.1016/j.semnephrol.2010.09.010
  8. Mahmoudjafari Z, Alencar MC, Alexander MD, Johnson DJ, Yeh J, Evans MD. Hematopoietic stem cell transplantation-associated thrombotic microangiopathy and the role of advanced practice providers and pharmacists. Bone Marrow Transplant. 2023;58(6):625-34. Available from: https://doi.org/10.1038/s41409-023-01951-3
  9. Seaby EG, Gilbert RD. Thrombotic microangiopathy following haematopoietic stem cell transplant. Pediatr Nephrol. 2018;33(9):1489-500. Available from: https://doi.org/10.1007/s00467-017-3803-4
  10. Schoettler ML, Gavriilaki E, Carreras E, Cho BK, Dandoy CE, Ho VT, et al. An ASTCT, CIBMTR, EBMT, and APBMT consensus statement defining response criteria for hematopoietic cell transplantation associated thrombotic microangiopathy (TA-TMA) directed therapy: Consensus response criteria for TA-TMA. Transplant Cell Ther. 2025. Available from: https://doi.org/10.1016/j.jtct.2025.05.028
  11. Kaszyńska A, Kępska-Dzilińska M, Karakulska-Prystupiuk E, Perkowska-Ptasińska A, Małyszko J. Kidney failure in the course of focal segmental glomerulonephritis in a patient after alloHSCT-a case study and review of the literature. J Nephrol. 2025;38(9):2983-9. Available from: https://doi.org/10.1007/s40620-025-02375-6
  12. Jodele S, Dandoy CE, Aguayo-Hiraldo P, Lane A, Teusink-Cross A, Sabulski A, et al. A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation–associated TMA. Blood. 2024;143(12):1112-23. Available from: https://doi.org/10.1182/blood.2023022526
  13. Acosta-Medina AA, Sridharan M, Go RS, Moyer AM, Leung N, Willrich MAV, et al. Clinical outcomes and treatment strategies of adult transplant-associated thrombotic microangiopathy: External validation of harmonizing definitions and high-risk criteria. Am J Hematol. 2025;100(5):830-9. Available from: https://doi.org/10.1002/ajh.27651

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?